Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy.
about
Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.Low-dose bevacizumab induces radiographic regression of vestibular schwannomas in neurofibromatosis type 2: A case report and literature reviewVascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosisDrug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.The role of vascular endothelial growth factor and vascular stability in diseases of the ear.Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients.The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2.Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2.Pathogenesis and management of type 2 neurofibromatosis
P2860
Q30364937-46B9E050-CA8F-4505-847F-B9C0AD2ABE26Q30385105-7A69C08E-97D9-4B35-A4C8-CF1E188F2985Q30393183-722B825B-7BD3-4CB6-AC89-6A6262037BC2Q30616602-B08D7EEC-7A7A-487C-8741-9438E6CE08E2Q38172070-46665A03-C7CD-4202-8612-7252EE2A0AF7Q39214055-3124382F-F02A-47A6-ACB7-5805A10D03D8Q47424261-42B103AE-2FC7-4835-8192-9080F6846210Q50352841-0B7758AB-A8AE-493E-B117-EA42B18A5295Q57266478-E954FC52-6966-4447-B3A5-1CD274FC1918
P2860
Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Bevacizumab treatment for vest ...... wth factor inhibition therapy.
@en
Bevacizumab treatment for vest ...... wth factor inhibition therapy.
@nl
type
label
Bevacizumab treatment for vest ...... wth factor inhibition therapy.
@en
Bevacizumab treatment for vest ...... wth factor inhibition therapy.
@nl
prefLabel
Bevacizumab treatment for vest ...... wth factor inhibition therapy.
@en
Bevacizumab treatment for vest ...... wth factor inhibition therapy.
@nl
P2093
P2860
P1476
Bevacizumab treatment for vest ...... wth factor inhibition therapy.
@en
P2093
G K Eminowicz
J Conibear
P N Plowman
P2860
P356
10.1017/S0022215111002805
P577
2011-10-18T00:00:00Z